Stowaways in the cargo: Contaminating nucleic acids in rAAV preparations for gene therapy
Authors:
Open Access
- 2 August 2023
- journal article
- review article
- Published by Elsevier in Molecular Therapy
- Vol. 31 (10) , 2826-2838
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- CpG-depleted adeno-associated virus vectors evade immune detectionJournal of Clinical Investigation, 2013
- Systemic Errors in Quantitative Polymerase Chain Reaction Titration of Self-Complementary Adeno-Associated Viral Vectors and Improved Alternative MethodsHuman Gene Therapy Methods, 2012
- Native Molecular State of Adeno-Associated Viral Vectors Revealed by Single-Molecule SequencingHuman Gene Therapy, 2012
- Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia BNew England Journal of Medicine, 2011
- Good Manufacturing Practice Production of Self-Complementary Serotype 8 Adeno-Associated Viral Vector for a Hemophilia B Clinical TrialHuman Gene Therapy, 2011
- Capsid-expressing DNA in AAV vectors and its elimination by use of an oversize capsid gene for vector productionGene Therapy, 2010
- A Simplified Baculovirus-AAV Expression Vector System Coupled With One-step Affinity Purification Yields High-titer rAAV Stocks From Insect CellsMolecular Therapy, 2009
- Improved antibiotic-free DNA vaccine vectors utilizing a novel RNA based plasmid selection systemVaccine, 2009
- An inducible system for highly efficient production of recombinant adeno-associated virus (rAAV) vectors in insect Sf9 cellsProceedings of the National Academy of Sciences, 2009
- Undetectable Transcription of cap in a Clinical AAV Vector: Implications for Preformed Capsid in Immune ResponsesMolecular Therapy, 2009